• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

Global and China Tumor Biomarker Test Market Size, Status and Forecast 2020-2026

report cover
  • 29 October 2020
  • Pharmaceuticals
  • 96 Pages
  • Report Code: 24LS-21711
  • Formate :   
Download FREE Report Sample Download PDF File

Tumor Biomarker Test -MARKET ADVISORY SERVICES

Global Tumor Biomarker Test Scope and Market Size
Tumor Biomarker Test market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Tumor Biomarker Test market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Prostate Specific Antigen Tests
CTC Tests
Alpha-Fetoprotein (AFP) Tests
CA Test
HER2 Tests
BRCA Test
Anaplastic Lymphoma Kinase (ALK) Tests
EGFR Mutation Tests
KRAS Test
Others

Market segment by Application, split into
Lung cancer
Breast cancer
Colorectal
Prostate Cancer
Blood Cancer

Based on regional and country-level analysis, the Tumor Biomarker Test market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Tumor Biomarker Test market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Abbott Laboratories, Inc.
Agilent Technologies
AstraZeneca
Becton Dickinson & Co.
Biocept Inc.
Cancer Genetics Inc.
Danaher Corporation
Foundation Medicine Inc.
Illumina Inc.
LabCorp Of America Holdings
Luminex Corporation
Myriad Genetics Inc.
NanoString Technologies Inc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor Biomarker Test Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Prostate Specific Antigen Tests
1.2.3 CTC Tests
1.2.4 Alpha-Fetoprotein (AFP) Tests
1.2.5 CA Test
1.2.6 HER2 Tests
1.2.7 BRCA Test
1.2.8 Anaplastic Lymphoma Kinase (ALK) Tests
1.2.9 EGFR Mutation Tests
1.2.10 KRAS Test
1.2.11 Others
1.3 Market by Application
1.3.1 Global Tumor Biomarker Test Market Share by Application: 2020 VS 2026
1.3.2 Lung cancer
1.3.3 Breast cancer
1.3.4 Colorectal
1.3.5 Prostate Cancer
1.3.6 Blood Cancer
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Tumor Biomarker Test Market Perspective (2015-2026)
2.2 Global Tumor Biomarker Test Growth Trends by Regions
2.2.1 Tumor Biomarker Test Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Tumor Biomarker Test Historic Market Share by Regions (2015-2020)
2.2.3 Tumor Biomarker Test Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Tumor Biomarker Test Players by Market Size
3.1.1 Global Top Tumor Biomarker Test Players by Revenue (2015-2020)
3.1.2 Global Tumor Biomarker Test Revenue Market Share by Players (2015-2020)
3.2 Global Tumor Biomarker Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Tumor Biomarker Test Revenue
3.4 Global Tumor Biomarker Test Market Concentration Ratio
3.4.1 Global Tumor Biomarker Test Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor Biomarker Test Revenue in 2019
3.5 Key Players Tumor Biomarker Test Area Served
3.6 Key Players Tumor Biomarker Test Product Solution and Service
3.7 Date of Enter into Tumor Biomarker Test Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Tumor Biomarker Test Breakdown Data by Type (2015-2026)
4.1 Global Tumor Biomarker Test Historic Market Size by Type (2015-2020)
4.2 Global Tumor Biomarker Test Forecasted Market Size by Type (2021-2026)

5 Tumor Biomarker Test Breakdown Data by Application (2015-2026)
5.1 Global Tumor Biomarker Test Historic Market Size by Application (2015-2020)
5.2 Global Tumor Biomarker Test Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Tumor Biomarker Test Market Size (2015-2026)
6.2 North America Tumor Biomarker Test Market Size by Type (2015-2020)
6.3 North America Tumor Biomarker Test Market Size by Application (2015-2020)
6.4 North America Tumor Biomarker Test Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada

7 Europe
7.1 Europe Tumor Biomarker Test Market Size (2015-2026)
7.2 Europe Tumor Biomarker Test Market Size by Type (2015-2020)
7.3 Europe Tumor Biomarker Test Market Size by Application (2015-2020)
7.4 Europe Tumor Biomarker Test Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe

8 China
8.1 China Tumor Biomarker Test Market Size (2015-2026)
8.2 China Tumor Biomarker Test Market Size by Type (2015-2020)
8.3 China Tumor Biomarker Test Market Size by Application (2015-2020)
8.4 China Tumor Biomarker Test Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific

9 Japan
9.1 Japan Tumor Biomarker Test Market Size (2015-2026)
9.2 Japan Tumor Biomarker Test Market Size by Type (2015-2020)
9.3 Japan Tumor Biomarker Test Market Size by Application (2015-2020)
9.4 Japan Tumor Biomarker Test Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil

10 Southeast Asia
10.1 Southeast Asia Tumor Biomarker Test Market Size (2015-2026)
10.2 Southeast Asia Tumor Biomarker Test Market Size by Type (2015-2020)
10.3 Southeast Asia Tumor Biomarker Test Market Size by Application (2015-2020)
10.4 Southeast Asia Tumor Biomarker Test Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa

11 Key Players Profiles
11.1 Abbott Laboratories, Inc.
11.1.1 Abbott Laboratories, Inc. Company Details
11.1.2 Abbott Laboratories, Inc. Business Overview
11.1.3 Abbott Laboratories, Inc. Tumor Biomarker Test Introduction
11.1.4 Abbott Laboratories, Inc. Revenue in Tumor Biomarker Test Business (2015-2020))
11.1.5 Abbott Laboratories, Inc. Recent Development
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Details
11.2.2 Agilent Technologies Business Overview
11.2.3 Agilent Technologies Tumor Biomarker Test Introduction
11.2.4 Agilent Technologies Revenue in Tumor Biomarker Test Business (2015-2020)
11.2.5 Agilent Technologies Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Tumor Biomarker Test Introduction
11.3.4 AstraZeneca Revenue in Tumor Biomarker Test Business (2015-2020)
11.3.5 AstraZeneca Recent Development
11.4 Becton Dickinson & Co.
11.4.1 Becton Dickinson & Co. Company Details
11.4.2 Becton Dickinson & Co. Business Overview
11.4.3 Becton Dickinson & Co. Tumor Biomarker Test Introduction
11.4.4 Becton Dickinson & Co. Revenue in Tumor Biomarker Test Business (2015-2020)
11.4.5 Becton Dickinson & Co. Recent Development
11.5 Biocept Inc.
11.5.1 Biocept Inc. Company Details
11.5.2 Biocept Inc. Business Overview
11.5.3 Biocept Inc. Tumor Biomarker Test Introduction
11.5.4 Biocept Inc. Revenue in Tumor Biomarker Test Business (2015-2020)
11.5.5 Biocept Inc. Recent Development
11.6 Cancer Genetics Inc.
11.6.1 Cancer Genetics Inc. Company Details
11.6.2 Cancer Genetics Inc. Business Overview
11.6.3 Cancer Genetics Inc. Tumor Biomarker Test Introduction
11.6.4 Cancer Genetics Inc. Revenue in Tumor Biomarker Test Business (2015-2020)
11.6.5 Cancer Genetics Inc. Recent Development
11.7 Danaher Corporation
11.7.1 Danaher Corporation Company Details
11.7.2 Danaher Corporation Business Overview
11.7.3 Danaher Corporation Tumor Biomarker Test Introduction
11.7.4 Danaher Corporation Revenue in Tumor Biomarker Test Business (2015-2020)
11.7.5 Danaher Corporation Recent Development
11.8 Foundation Medicine Inc.
11.8.1 Foundation Medicine Inc. Company Details
11.8.2 Foundation Medicine Inc. Business Overview
11.8.3 Foundation Medicine Inc. Tumor Biomarker Test Introduction
11.8.4 Foundation Medicine Inc. Revenue in Tumor Biomarker Test Business (2015-2020)
11.8.5 Foundation Medicine Inc. Recent Development
11.9 Illumina Inc.
11.9.1 Illumina Inc. Company Details
11.9.2 Illumina Inc. Business Overview
11.9.3 Illumina Inc. Tumor Biomarker Test Introduction
11.9.4 Illumina Inc. Revenue in Tumor Biomarker Test Business (2015-2020)
11.9.5 Illumina Inc. Recent Development
11.10 LabCorp Of America Holdings
11.10.1 LabCorp Of America Holdings Company Details
11.10.2 LabCorp Of America Holdings Business Overview
11.10.3 LabCorp Of America Holdings Tumor Biomarker Test Introduction
11.10.4 LabCorp Of America Holdings Revenue in Tumor Biomarker Test Business (2015-2020)
11.10.5 LabCorp Of America Holdings Recent Development
11.11 Luminex Corporation
10.11.1 Luminex Corporation Company Details
10.11.2 Luminex Corporation Business Overview
10.11.3 Luminex Corporation Tumor Biomarker Test Introduction
10.11.4 Luminex Corporation Revenue in Tumor Biomarker Test Business (2015-2020)
10.11.5 Luminex Corporation Recent Development
11.12 Myriad Genetics Inc.
10.12.1 Myriad Genetics Inc. Company Details
10.12.2 Myriad Genetics Inc. Business Overview
10.12.3 Myriad Genetics Inc. Tumor Biomarker Test Introduction
10.12.4 Myriad Genetics Inc. Revenue in Tumor Biomarker Test Business (2015-2020)
10.12.5 Myriad Genetics Inc. Recent Development
11.13 NanoString Technologies Inc.
10.13.1 NanoString Technologies Inc. Company Details
10.13.2 NanoString Technologies Inc. Business Overview
10.13.3 NanoString Technologies Inc. Tumor Biomarker Test Introduction
10.13.4 NanoString Technologies Inc. Revenue in Tumor Biomarker Test Business (2015-2020)
10.13.5 NanoString Technologies Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables

Table 1. Global Tumor Biomarker Test Market Size Growth Rate by Type (US$ Million): 2020 VS 2026

Table 3. Key Players of Prostate Specific Antigen Tests

Table 4. Key Players of CTC Tests

Table 5. Key Players of Alpha-Fetoprotein (AFP) Tests

Table 6. Key Players of CA Test

Table 7. Key Players of HER2 Tests

Table 8. Key Players of BRCA Test

Table 9. Key Players of Anaplastic Lymphoma Kinase (ALK) Tests

Table 10. Key Players of EGFR Mutation Tests

Table 11. Key Players of KRAS Test

Table 12. Key Players of Others

Table 13. Global Tumor Biomarker Test Market Size Growth by Application (US$ Million): 2020 VS 2026

Table 14. Global Tumor Biomarker Test Market Size by Regions (US$ Million): 2020 VS 2026

Table 15. Global Tumor Biomarker Test Market Size by Regions (2015-2020) (US$ Million)

Table 16. Global Tumor Biomarker Test Market Share by Regions (2015-2020)

Table 17. Global Tumor Biomarker Test Forecasted Market Size by Regions (2021-2026) (US$ Million)

Table 18. Global Tumor Biomarker Test Market Share by Regions (2021-2026)

Table 19. Tumor Biomarker Test Market Market Trends

Table 20. Tumor Biomarker Test Market Drivers

Table 21. Tumor Biomarker Test Market Challenges

Table 22. Tumor Biomarker Test Market Restraints

Table 23. Global Tumor Biomarker Test Revenue by Players (2015-2020) (US$ Million)

Table 24. Global Tumor Biomarker Test Market Share by Players (2015-2020)

Table 25. Global Top Tumor Biomarker Test Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Biomarker Test as of 2019)

Table 26. Global Tumor Biomarker Test by Players Market Concentration Ratio (CR5 and HHI)

Table 27. Key Players Headquarters and Area Served

Table 28. Key Players Tumor Biomarker Test Product Solution and Service

Table 29. Mergers & Acquisitions, Expansion Plans

Table 30. Global Tumor Biomarker Test Market Size by Type (2015-2020) (US$ Million)

Table 31. Global Tumor Biomarker Test Market Size Share by Type (2015-2020)

Table 32. Global Tumor Biomarker Test Revenue Market Share by Type (2021-2026)

Table 33. Global Tumor Biomarker Test Market Size Share by Application (2015-2020)

Table 34. Global Tumor Biomarker Test Market Size by Application (2015-2020) (US$ Million)

Table 35. Global Tumor Biomarker Test Market Size Share by Application (2021-2026)

Table 36. North America Tumor Biomarker Test Market Size by Type (2015-2020) (US$ Million)

Table 37. North America Tumor Biomarker Test Market Share by Type (2015-2020)

Table 38. North America Tumor Biomarker Test Market Size by Application (2015-2020) (US$ Million)

Table 39. North America Tumor Biomarker Test Market Share by Application (2015-2020)

Table 40. North America Tumor Biomarker Test Market Size by Country (US$ Million) (2015-2020)

Table 41. North America Tumor Biomarker Test Market Share by Country (2015-2020)

Table 42. Europe Tumor Biomarker Test Market Size by Type (2015-2020) (US$ Million)

Table 43. Europe Tumor Biomarker Test Market Share by Type (2015-2020)

Table 44. Europe Tumor Biomarker Test Market Size by Application (2015-2020) (US$ Million)

Table 45. Europe Tumor Biomarker Test Market Share by Application (2015-2020)

Table 46. Europe Tumor Biomarker Test Market Size by Country (US$ Million) (2015-2020)

Table 47. Europe Tumor Biomarker Test Market Share by Country (2015-2020)

Table 48. China Tumor Biomarker Test Market Size by Type (2015-2020) (US$ Million)

Table 49. China Tumor Biomarker Test Market Share by Type (2015-2020)

Table 50. China Tumor Biomarker Test Market Size by Application (2015-2020) (US$ Million)

Table 51. China Tumor Biomarker Test Market Share by Application (2015-2020)

Table 52. China Tumor Biomarker Test Market Size by Region (US$ Million) (2015-2020)

Table 53. China Tumor Biomarker Test Market Share by Region (2015-2020)

Table 54. Japan Tumor Biomarker Test Market Size by Type (2015-2020) (US$ Million)

Table 55. Japan Tumor Biomarker Test Market Share by Type (2015-2020)

Table 56. Japan Tumor Biomarker Test Market Size by Application (2015-2020) (US$ Million)

Table 57. Japan Tumor Biomarker Test Market Share by Application (2015-2020)

Table 58. Japan Tumor Biomarker Test Market Size by Country (US$ Million) (2015-2020)

Table 59. Japan Tumor Biomarker Test Market Share by Country (2015-2020)

Table 60. Southeast Asia Tumor Biomarker Test Market Size by Type (2015-2020) (US$ Million)

Table 61. Southeast Asia Tumor Biomarker Test Market Share by Type (2015-2020)

Table 62. Southeast Asia Tumor Biomarker Test Market Size by Application (2015-2020) (US$ Million)

Table 63. Southeast Asia Tumor Biomarker Test Market Share by Application (2015-2020)

Table 64. Southeast Asia Tumor Biomarker Test Market Size by Country (US$ Million) (2015-2020)

Table 65. Southeast Asia Tumor Biomarker Test Market Share by Country (2015-2020)

Table 66. Abbott Laboratories, Inc. Company Details

Table 67. Abbott Laboratories, Inc. Business Overview

Table 68. Abbott Laboratories, Inc. Product

Table 69. Abbott Laboratories, Inc. Revenue in Tumor Biomarker Test Business (2015-2020) (US$ Million)

Table 70. Abbott Laboratories, Inc. Recent Development

Table 71. Agilent Technologies Company Details

Table 72. Agilent Technologies Business Overview

Table 73. Agilent Technologies Product

Table 74. Agilent Technologies Revenue in Tumor Biomarker Test Business (2015-2020) (US$ Million)

Table 75. Agilent Technologies Recent Development

Table 76. AstraZeneca Company Details

Table 77. AstraZeneca Business Overview

Table 78. AstraZeneca Product

Table 79. AstraZeneca Revenue in Tumor Biomarker Test Business (2015-2020) (US$ Million)

Table 80. AstraZeneca Recent Development

Table 81. Becton Dickinson & Co. Company Details

Table 82. Becton Dickinson & Co. Business Overview

Table 83. Becton Dickinson & Co. Product

Table 84. Becton Dickinson & Co. Revenue in Tumor Biomarker Test Business (2015-2020) (US$ Million)

Table 85. Becton Dickinson & Co. Recent Development

Table 86. Biocept Inc. Company Details

Table 87. Biocept Inc. Business Overview

Table 88. Biocept Inc. Product

Table 89. Biocept Inc. Revenue in Tumor Biomarker Test Business (2015-2020) (US$ Million)

Table 90. Biocept Inc. Recent Development

Table 91. Cancer Genetics Inc. Company Details

Table 92. Cancer Genetics Inc. Business Overview

Table 93. Cancer Genetics Inc. Product

Table 94. Cancer Genetics Inc. Revenue in Tumor Biomarker Test Business (2015-2020) (US$ Million)

Table 95. Cancer Genetics Inc. Recent Development

Table 96. Danaher Corporation Company Details

Table 97. Danaher Corporation Business Overview

Table 98. Danaher Corporation Product

Table 99. Danaher Corporation Revenue in Tumor Biomarker Test Business (2015-2020) (US$ Million)

Table 100. Danaher Corporation Recent Development

Table 101. Foundation Medicine Inc. Business Overview

Table 102. Foundation Medicine Inc. Product

Table 103. Foundation Medicine Inc. Company Details

Table 104. Foundation Medicine Inc. Revenue in Tumor Biomarker Test Business (2015-2020) (US$ Million)

Table 105. Foundation Medicine Inc. Recent Development

Table 106. Illumina Inc. Company Details

Table 107. Illumina Inc. Business Overview

Table 108. Illumina Inc. Product

Table 109. Illumina Inc. Revenue in Tumor Biomarker Test Business (2015-2020) (US$ Million)

Table 110. Illumina Inc. Recent Development

Table 111. LabCorp Of America Holdings Company Details

Table 112. LabCorp Of America Holdings Business Overview

Table 113. LabCorp Of America Holdings Product

Table 114. LabCorp Of America Holdings Revenue in Tumor Biomarker Test Business (2015-2020) (US$ Million)

Table 115. LabCorp Of America Holdings Recent Development

Table 116. Luminex Corporation Company Details

Table 117. Luminex Corporation Business Overview

Table 118. Luminex Corporation Product

Table 119. Luminex Corporation Revenue in Tumor Biomarker Test Business (2015-2020) (US$ Million)

Table 120. Luminex Corporation Recent Development

Table 121. Myriad Genetics Inc. Company Details

Table 122. Myriad Genetics Inc. Business Overview

Table 123. Myriad Genetics Inc. Product

Table 124. Myriad Genetics Inc. Revenue in Tumor Biomarker Test Business (2015-2020) (US$ Million)

Table 125. Myriad Genetics Inc. Recent Development

Table 126. NanoString Technologies Inc. Company Details

Table 127. NanoString Technologies Inc. Business Overview

Table 128. NanoString Technologies Inc. Product

Table 129. NanoString Technologies Inc. Revenue in Tumor Biomarker Test Business (2015-2020) (US$ Million)

Table 130. NanoString Technologies Inc. Recent Development

Table 131. Research Programs/Design for This Report

Table 132. Key Data Information from Secondary Sources

Table 133. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Tumor Biomarker Test Market Share by Type: 2020 VS 2026

Figure 2. Prostate Specific Antigen Tests Features

Figure 3. CTC Tests Features

Figure 4. Alpha-Fetoprotein (AFP) Tests Features

Figure 5. CA Test Features

Figure 6. HER2 Tests Features

Figure 7. BRCA Test Features

Figure 8. Anaplastic Lymphoma Kinase (ALK) Tests Features

Figure 9. EGFR Mutation Tests Features

Figure 10. KRAS Test Features

Figure 11. Others Features

Figure 12. Global Tumor Biomarker Test Market Share by Application: 2020 VS 2026

Figure 13. Lung cancer Case Studies

Figure 14. Breast cancer Case Studies

Figure 15. Colorectal Case Studies

Figure 16. Prostate Cancer Case Studies

Figure 17. Blood Cancer Case Studies

Figure 18. Tumor Biomarker Test Report Years Considered

Figure 19. Global Tumor Biomarker Test Market Size (US$ Million), YoY Growth 2015-2026

Figure 20. Global Tumor Biomarker Test Market Share by Regions: 2020 VS 2026

Figure 21. Global Tumor Biomarker Test Market Share by Regions (2021-2026)

Figure 22. Global Tumor Biomarker Test Market Share by Players in 2019

Figure 23. Global Top Tumor Biomarker Test Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Biomarker Test as of 2019

Figure 24. The Top 10 and 5 Players Market Share by Tumor Biomarker Test Revenue in 2019

Figure 25. North America Tumor Biomarker Test Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 26. United States Tumor Biomarker Test Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 27. Canada Tumor Biomarker Test Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 28. Europe Tumor Biomarker Test Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 29. Germany Tumor Biomarker Test Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 30. France Tumor Biomarker Test Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 31. U.K. Tumor Biomarker Test Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 32. Italy Tumor Biomarker Test Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 33. Russia Tumor Biomarker Test Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 34. Nordic Tumor Biomarker Test Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 35. Rest of Europe Tumor Biomarker Test Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 36. Asia-Pacific Tumor Biomarker Test Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 37. China Tumor Biomarker Test Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 38. Japan Tumor Biomarker Test Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 39. South Korea Tumor Biomarker Test Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 40. Southeast Asia Tumor Biomarker Test Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 41. India Tumor Biomarker Test Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 42. Australia Tumor Biomarker Test Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 43. Rest of Asia-Pacific Tumor Biomarker Test Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 44. Latin America Tumor Biomarker Test Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 45. Mexico Tumor Biomarker Test Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 46. Brazil Tumor Biomarker Test Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 47. Middle East & Africa Tumor Biomarker Test Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 48. Turkey Tumor Biomarker Test Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 49. Saudi Arabia Tumor Biomarker Test Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 50. UAE Tumor Biomarker Test Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 51. Rest of Middle East & Africa Tumor Biomarker Test Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 52. Abbott Laboratories, Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2015-2020)

Figure 53. Agilent Technologies Revenue Growth Rate in Tumor Biomarker Test Business (2015-2020)

Figure 54. AstraZeneca Revenue Growth Rate in Tumor Biomarker Test Business (2015-2020)

Figure 55. Becton Dickinson & Co. Revenue Growth Rate in Tumor Biomarker Test Business (2015-2020)

Figure 56. Biocept Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2015-2020)

Figure 57. Cancer Genetics Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2015-2020)

Figure 58. Danaher Corporation Revenue Growth Rate in Tumor Biomarker Test Business (2015-2020)

Figure 59. Foundation Medicine Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2015-2020)

Figure 60. Illumina Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2015-2020)

Figure 61. LabCorp Of America Holdings Revenue Growth Rate in Tumor Biomarker Test Business (2015-2020)

Figure 62. Luminex Corporation Revenue Growth Rate in Tumor Biomarker Test Business (2015-2020)

Figure 63. Myriad Genetics Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2015-2020)

Figure 64. NanoString Technologies Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2015-2020)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

Abbott Laboratories, Inc.

Agilent Technologies

AstraZeneca

Becton Dickinson & Co.

Biocept Inc.

Cancer Genetics Inc.

Danaher Corporation

Foundation Medicine Inc.

Illumina Inc.

LabCorp Of America Holdings

Luminex Corporation

Myriad Genetics Inc.

NanoString Technologies Inc.

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $2925

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase